Velentium vs TTP: full comparison for 2026
Quick verdict
Velentium (4.5/5) edges ahead of TTP (4.4/5) overall. Velentium is the better choice for implantables and FDA cybersecurity submissions. TTP is the stronger option for pharma device programs, inhalers and injectors. The right choice depends on your project size, budget, and required tech stack.
Velentium vs TTP: head-to-head summary
| Criterion | Velentium | TTP |
|---|---|---|
| Founded | 2012 | 1987 |
| HQ | Katy, TX, USA | Melbourn, Cambridgeshire, UK |
| Team size | 51–250 | Not published |
| Rating | 4.5 / 5 | 4.4 / 5 |
| Primary differentiator | Combines active-implantable engineering with a dedicated device cybersecurity team that prepares FDA premarket security documentation | Employee ownership plus long-running drug delivery and surgical device work for large pharma and medtech clients |
| Pricing model | Fixed project, time and materials, manufacturing contract | Time and materials, phased fixed project |
| Min. engagement | Not disclosed | Not disclosed |
| Primary tech stack | Embedded C/C++, RTOS, BLE | Ultrasound, Microfluidics, Embedded C/C++ |
| Industries served | Implantables & neuromodulation, Surgical & therapeutic devices, Wearables & remote monitoring | Drug delivery, Surgical & robotics, Diagnostics & lab devices |
Velentium vs TTP: overview
Velentium
Velentium was founded in 2012 and is based in Katy, near Houston, Texas. It designs, develops and manufactures active medical devices, including implantables and their programmers, and offers systems engineering, firmware, software, cybersecurity and CGMP manufacturing. Great Point Partners completed a growth recapitalization in 2021, the company sold its oil and gas division in 2023 to focus fully on medtech, and it took $15M in growth financing from Trinity Capital in 2024. Headcount estimates range from 51 to 250.
TTP
TTP (The Technology Partnership) has operated for around 40 years from its own science park in Melbourn, South Cambridgeshire. In December 2021 TTP Group moved to 100% employee ownership through an Employee Ownership Trust. Its Medical Devices team works on drug delivery, surgical systems and diagnostics, and the wider company does deep technology work in sectors such as life science instruments and industrial products. Headcount is not published in a form we could verify.
Services and capabilities: Velentium vs TTP
| Capability | Velentium | TTP |
|---|---|---|
| Electronics & PCB design | ✓ | ✓ |
| Firmware & embedded software | ✓ | ✓ |
| SaMD & companion apps | ✗ | ✗ |
| Connected devices & IoT | ✗ | ✗ |
| Industrial design & human factors | ✗ | ✗ |
| Mechanical engineering | ✗ | ✓ |
| Device cybersecurity | ✓ | ✗ |
| Regulatory & QMS support | ✓ | ✓ |
| Manufacturing & scale-up | ✓ | ✗ |
Tech stack comparison: Velentium vs TTP
| Framework / platform | Velentium | TTP |
|---|---|---|
| Embedded C/C++ | ✓ | ✓ |
| Embedded Linux | N/A | N/A |
| RTOS | ✓ | N/A |
| BLE | ✓ | N/A |
| Cloud (AWS/Azure) | N/A | N/A |
| IEC 62304 | ✓ | N/A |
| ISO 14971 | ✓ | N/A |
| ISO 13485 QMS | N/A | ✓ |
| Qt | N/A | N/A |
Pricing comparison: Velentium vs TTP
| Criterion | Velentium | TTP |
|---|---|---|
| Minimum engagement | Not disclosed | Not disclosed |
| Engagement models | Fixed project, Manufacturing contract, Time & materials | Consulting, Fixed project, Time & materials |
| Rate transparency | Not public | Not public |
| Price tier | Mid-market | Mid-market |
Target audience comparison: Velentium vs TTP
| Dimension | Velentium | TTP |
|---|---|---|
| Best company size | Startup to mid-market | Startup to mid-market |
| Best industries | Implantables & neuromodulation, Surgical & therapeutic devices, Wearables & remote monitoring | Drug delivery, Surgical & robotics, Diagnostics & lab devices |
| Best use cases | Building a neurostimulator and its clinician programmer, Preparing the cybersecurity section of an FDA 510(k) or PMA | Designing an autoinjector or inhaler for a pharma combination product, Developing a surgical energy device |
| Typical project type | Fixed project | Consulting |
Velentium vs TTP: pros and cons
| Velentium | |
|---|---|
| + | Cybersecurity is a full practice here, covering threat modeling, SBOMs, testing and postmarket monitoring |
| + | Experience with active implantable devices, one of the hardest device categories to engineer and certify |
| + | Can manufacture Class II and III devices after development, reducing transfer risk |
| + | Offers training on device cybersecurity, which helps client teams keep up after hand-off |
| - | Private-equity recapitalization and debt financing mean ownership priorities may shift over time |
| - | Smaller than the large consultancies, so very broad programs may stretch the team |
| - | Industrial design and human factors are not its main strength |
| TTP | |
|---|---|
| + | Employee ownership since 2021 removes pressure from outside investors |
| + | Well regarded for drug delivery devices, an area where mechanics and human factors decide success |
| + | Own science park with lab and workshop space for physical prototyping |
| + | Specialist depth in ultrasound and fluidics |
| - | Does not publish headcount or rates, which makes early budgeting harder |
| - | UK-centric delivery; US clients work across time zones |
| - | Pricing sits with the premium Cambridge consultancies |
Who should choose Velentium?
A typical fit: building a neurostimulator and its clinician programmer.
Combines active-implantable engineering with a dedicated device cybersecurity team that prepares FDA premarket security documentation. Minimum engagement is not publicly disclosed. Works best with clients in Implantables & neuromodulation, Surgical & therapeutic devices, Wearables & remote monitoring.
Who should choose TTP?
A typical fit: designing an autoinjector or inhaler for a pharma combination product.
Employee ownership plus long-running drug delivery and surgical device work for large pharma and medtech clients. Minimum engagement is not publicly disclosed. Works best with clients in Drug delivery, Surgical & robotics, Diagnostics & lab devices.
Decision matrix: Velentium vs TTP
| Your situation | Recommended choice |
|---|---|
| You need full-ownership delivery on a defined project scope | Velentium |
| You need a large dedicated team for an ongoing programme | Check each company's engagement model |
| Your budget is at the lower end | Compare: Velentium (Not disclosed) vs TTP (Not disclosed) |
| You need specialist depth in a specific vertical | Velentium |
| You need staff augmentation or team extension | Neither; consider alternatives that offer staff aug |
| You need consulting before committing to a build | Both may offer discovery engagements |
Use case fit: Velentium vs TTP
| Use case | Velentium fit | TTP fit | Winner |
|---|---|---|---|
| Building a neurostimulator and its clinician programmer | Strong | Limited | Velentium |
| Preparing the cybersecurity section of an FDA 510(k) or PMA | Strong | Limited | Velentium |
| Designing an autoinjector or inhaler for a pharma combination product | Limited | Strong | TTP |
| Developing a surgical energy device | Limited | Strong | TTP |
Verdict: Velentium vs TTP
Velentium (4.5/5) is the stronger overall choice for most Medical Device Development projects. Combines active-implantable engineering with a dedicated device cybersecurity team that prepares FDA premarket security documentation.
TTP (4.4/5) is worth a look if you need developing a surgical energy device. If your situation matches that, TTP is a competitive option.
Related comparisons
Velentium vs TTP FAQ
Is Velentium better than TTP?
Velentium (4.5/5) scores higher overall, but "better" depends on your use case. Velentium's strongest advantage: cybersecurity is a full practice here, covering threat modeling, SBOMs, testing and postmarket monitoring. TTP's strongest advantage: employee ownership since 2021 removes pressure from outside investors.
How do Velentium and TTP differ in pricing?
Velentium uses fixed project, time and materials, manufacturing contract pricing. TTP uses time and materials, phased fixed project pricing. Neither firm publishes a full rate card; a discovery call is required for project-specific quotes.
Which is better for enterprise: Velentium or TTP?
Velentium is the larger team and typically the better enterprise-scale choice. For very large programmes, verify team size and compliance coverage directly with each company before shortlisting.
What are the main differences between Velentium and TTP?
Velentium's primary differentiator is: combines active-implantable engineering with a dedicated device cybersecurity team that prepares FDA premarket security documentation. TTP's primary differentiator is: employee ownership plus long-running drug delivery and surgical device work for large pharma and medtech clients. They also differ in team size (51–250 vs Not published), minimum engagement (Not disclosed vs Not disclosed), and primary industries served (Implantables & neuromodulation, Surgical & therapeutic devices vs Drug delivery, Surgical & robotics).
Verify all details directly with each company before making a decision.